Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001854270-25-000015
Filing Date
2025-03-10
Accepted
2025-03-10 19:02:52
Documents
1
Period of Report
2025-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741647766.html 4  
1 FORM 4 wk-form4_1741647766.xml 4 6582
  Complete submission text file 0001854270-25-000015.txt   8303
Mailing Address C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Rajangam Kanya (Reporting) CIK: 0001816676 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40440 | Film No.: 25725375

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)